针对雇主的网络版MiLES干预提升癌症员工成功复工的有效性、成本效果与投资回报:随机对照试验设计
MiLES干预是面向雇主的数字工具,通过互动视频、对话清单与提示信息提升雇主支持癌症员工复工的意愿、能力与自我效能。本文描述一项随机对照试验设计,纳入140对雇主-雇员二元组,随访12个月,评估成功复工、成本效果与投资回报,并同步开展过程评价。
要点
- MiLES干预为面向雇主的数字工具,旨在通过互动视频、对话清单与提示信息提升癌症员工复工。
- 随机对照试验纳入140对雇主-雇员二元组,随访12个月,干预组雇主获得MiLES干预,对照组接受常规照护。
- 主要结局为雇员层面的成功复工,次要结局包括复工时间、生活质量、工作生活质量及雇主自我效能等。
核心结论
- 本随机对照试验将研究MiLES干预的有效性、成本效果与投资回报,以期为在研究环境之外实施MiLES干预提供建议。
研究设计与样本
- 一项随机对照试验,随访12个月,纳入140对雇主-雇员二元组。
- 雇员条件为确诊癌症(<2年前)、年龄18-67岁、受雇于雇主且有薪就业、当前完全或部分病假(<2年),雇主为该雇员提供复工支持。
- 二元组随机分配至干预组(雇主获得MiLES干预)或对照组(常规照护)。
- 同步开展过程评价,采用英国MRC框架。
主要发现
- 主要结局为雇员层面的成功复工(涵盖雇员对复工的视角)。
- 次要结局包括复工时间、生活质量与工作生活质量、获得的工作相关支持及对工作相关支持的满意度。
- 雇主层面的次要结局包括提供复工支持的自我效能及对复工过程的满意度。
- 所有结局通过基线及随访3、6、12个月时的问卷评估。
- 成本效果与投资回报分析均从雇主角度开展。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The MiLES intervention is a digital employer-based tool aimed at enhancing return to work (RTW) of employees with cancer through interactive videos, conversation checklists and tips and information. In a previous study, the MiLES intervention proved to be a useful intervention that aligns with employers' daily practice. The hypothesis is that the MiLES intervention will enhance the employers' willingness, ability and self-efficacy in providing RTW support, which in turn will enhance the RTW of employees with cancer. This paper describes the design of a randomized controlled trial (RCT), aimed at evaluating the effectiveness, cost-effectiveness and return on investment of the MiLES intervention. Parallel to the RCT, a process evaluation of the delivery of the MiLES intervention in a real-world setting will be conducted. METHODS: An RCT with a 12-month follow-up period will be conducted involving 140 employer-employee dyads. The employees are diagnosed with cancer (< 2 years earlier), aged 18-67 years, in paid employment with an employer, and currently fully or partly sick-listed (< 2 years). The employer provides RTW support to the included employee. All dyads will either be allocated to the intervention group, of which the employer will get access to the MiLES intervention, or to the control group in which care as usual will be provided. The primary outcome will be successful RTW (encompassing the employee's perspectives on RTW) at the level of the employee; secondary outcomes will include the following: time to RTW, quality of life and quality of working life, received work-related support, and satisfaction with work-related support. At the level of the employer, the secondary outcomes will include the following: self-efficacy in providing RTW support and satisfaction with the RTW process. All outcomes will be assessed using questionnaires at baseline and at 3, 6 and 12 months of follow-up. Both the cost-effectiveness and the return on investment analysis will be conducted from the employers perspective. For the process evaluation, the UK MRC framework will be used. DISCUSSION: This RCT will study the effectiveness, cost-effectiveness and return on investment of the MiLES intervention. This knowledge is needed to formulate recommendations regarding the implementation of the MiLES intervention beyond the research setting. TRIAL REGISTRATION: ClinicalTrials.gov, NCT06672887. Registered on October 25, 2024.
引用
- Mollet JM, Greidanus MA, Boot CRL, et al. Effectiveness, cost-effectiveness, and return on investment of the web-based MiLES intervention targeted at employers, to enhance successful return to work of employees with cancer: design of a randomized controlled trial. Trials. 2025. PMID: 41102780. doi:10.1186/s13063-025-09092-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。